sdrwt, Author at ImmuneBiotech

About sdrwt

This author has not yet filled in any details.
So far sdrwt has created 6 blog entries.

ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders

Press Release Lund, Sweden, January 20 2021 [...]

sdrwt2023-05-14T13:33:23+02:00

ImmuneBiotech: Patent granted for GutMagnific® in the United States

Press Release Lund, Sweden, October 16 2019 [...]

sdrwt2023-05-14T14:00:58+02:00

ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic

Press Release Lund, Sweden, June 10 2020 [...]

sdrwt2023-05-14T14:01:56+02:00

ImmuneBiotech: market launch of first product GutMagnific

Press Release Lund, Sweden, October 16 2019 [...]

sdrwt2023-05-14T13:37:35+02:00

ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 1

Press Release Lund, Sweden, May 7 2019 [...]

sdrwt2023-05-14T13:35:17+02:00

ImmuneBiotech closes new share issue with funding from recognized international investors and business angels

Press Release Lund, Sweden, January 24, 201 [...]

sdrwt2023-05-14T13:35:30+02:00